Clinical Manifestations of Persistent Smear Positive and Culture Negative Sputum Tests 5 Months after First-Line Anti-Tuberculous Chemotherapy
![]() ![]() |
Kim, Do Hyung
(National Masan Hospital)
Hwang, Su Hee (National Masan Hospital) Cheon, Du Su (National Masan Hospital) Min, Jin Hong (National Masan Hospital) Kang, Hyung Seok (National Masan Hospital) Park, Seung Gyu (National Masan Hospital) |
1 | British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First report: results during chemotherapy. Br J Dis Chest 1981;75:141-53 DOI ScienceOn |
2 | Frieden T. Toman's Tuberculosis: case detection, treatment, and monitoring - questions and answers. 2nd ed. Geneva: World Health Organization; 2004 |
3 | Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis 2007;11: 828-37 |
4 | Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171:1430-5. DOI ScienceOn |
5 | Ormerod LP, Horsfield N, Green RM. Can a nine-month regimen be used to treat isoniazid resistant tuberculosis diagnosed after standard treatment is started? J Infect 2001;42:1-3 DOI ScienceOn |
6 | Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998;12:505-10 DOI ScienceOn |
7 | Kim TC, Blackman RS, Heatwole KM, Kim T, Rochester DF. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Am Rev Respir Dis 1984;129: 264-8 |
8 | Vidal R, Martin-Casabona N, Juan A, Falgueras T, Miravitlles M. Incidence and significance of acid fast bacilli in sputum smears at the end of antituberculous treatment. Chest 1996;109:1562-5 DOI ScienceOn |
9 | Tam CM, Chan SL, Kam KM, Goodall RL, Mitchison DA. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. Int J Tuberc Lung Dis 2002; 6:3-10 |
10 | Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest 1999;116:726–31 |
11 | Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167: 603-62 DOI ScienceOn |
12 | Sundaram V, Fujiwara PI, Driver CR, Osahan SS, Munsiff SS. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion. Int J Tuberc Lung Dis 2002;6:238-45 |
13 | National Tuberculosis Association of the USA. Diagnostic standards and classification of tuberculosis. New York: National Tuberculosis Association; 1961 |
14 | Guler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007;61:231-5 DOI ScienceOn |
15 | Chang SC, Yoon YM, Hong YP. Relapse rates within one year after the completion of treatment with short course chemotherapy for pulmonary tuberculosis under programme conditions. Tuberc Respir Dis 1987;34: 137-43 |
16 | Korea Center for Disease Control & Prevention. 2007 Tuberculosis. Seoul:Korea Center for Disease Control & Prevention;2007 |
17 | Koh WJ, Kwon OJ, Yu CM, Jeon K, Kim KC, Lee BH, et al. Treatment of isoniazid-resistant pulmonary tuberculosis. Tuberc Respir Dis 2004;56:248-60 DOI |
![]() |